Publication:
Effects of Dopaminergic Compounds on Carbonic Anhydrase Isozymes I, II, and VI

dc.authorscopusid23013520200
dc.authorscopusid23027537500
dc.authorscopusid6701789599
dc.authorscopusid7102904152
dc.contributor.authorŞentürk, M.
dc.contributor.authorEkinci, D.
dc.contributor.authorGöksu, S.
dc.contributor.authorSupuran, C.T.
dc.date.accessioned2020-06-21T14:27:45Z
dc.date.available2020-06-21T14:27:45Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Şentürk] Murat, Department of Chemistry, Aǧrı İbrahim Çeçen Üniversitesi, Agri, Agri, Turkey; [Ekinci] Deniz, Department of Agricultural Biotechnology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Göksu] Süleyman, Department of Chemistry, Atatürk Üniversitesi, Erzurum, Erzurum, Turkey; [Supuran] Claudiu T., Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, FI, Italyen_US
dc.description.abstractStudies on carbonic anhydrase (CA, EC 4.2.1.1) inhibitors have increased due to several therapeutic applications while there are few investigations on activators. Here we investigated CA inhibitory and activatory capacities of a series of dopaminergic compounds on human carbonic anhydrase (hCA) isozymes I, II, and VI. 2-Amino-1,2,3,4-tetrahydronaphthalene-6,7-diol hydrobromide and 2-amino-1,2,3,4-tetrahydronaphthalene-5,6-diol hydrobromide were found to show effective inhibitory action on hCA I and II whereas 2-amino-5,6-dibromoindan hydrobromide and 2-amino-5-bromoindan hydrobromide exhibited only moderate inhibition against both isoforms, being more effective inhibitors of hCA VI. Ki values of the molecules 36 were in the range of 41.12-363 μM against hCA I, of 0.381-470 μM against hCA II and of 0.578-1.152 μM against hCA VI, respectively. Compound 7 behaved as a CA activator with K<inf>A</inf> values of 27.3 μM against hCA I, of 18.4 μM against hCA II and of 8.73 μM against hCA VI, respectively. © 2012 Informa UK, Ltd.en_US
dc.identifier.doi10.3109/14756366.2011.591290
dc.identifier.endpage369en_US
dc.identifier.issn1475-6366
dc.identifier.issn1475-6374
dc.identifier.issue3en_US
dc.identifier.pmid21699374
dc.identifier.scopus2-s2.0-84860360752
dc.identifier.scopusqualityQ1
dc.identifier.startpage365en_US
dc.identifier.urihttps://doi.org/10.3109/14756366.2011.591290
dc.identifier.volume27en_US
dc.identifier.wosWOS:000303330100006
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.relation.journalJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCarbonic Anhydraseen_US
dc.subjectDopaminergicen_US
dc.subjectHCA Ien_US
dc.subjectHCA IIen_US
dc.subjectInhibitoren_US
dc.titleEffects of Dopaminergic Compounds on Carbonic Anhydrase Isozymes I, II, and VIen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files